TSE:4519Pharmaceuticals
Chugai Pharmaceutical (TSE:4519) Margins Remain Strong, Reinforcing Bullish Narratives Despite Slower Earnings Growth
Chugai Pharmaceutical (TSE:4519) posted earnings growth of 2.6% in the last year and has grown at an average rate of 10.7% annually over the past five years. Its net profit margin eased slightly to 32.7% from last year’s 33.9%, while analysts expect revenue and earnings to keep moving ahead of local industry averages. As investors consider the company’s robust margins and projected above-market growth, recent moderation in growth rates and share price trends may play a key role in shaping...